Literature DB >> 21580788

2-Methyl-3-(n-octylsulfan-yl)quinoxaline.

Youssef Ramli, Rachid Slimani, Hafid Zouihri, Saïd Lazar, E M Essassi.   

Abstract

All the non-H atoms of the title compound, C(17)H(24)N(2)S, lie almost in a common plane (r.m.s. deviation = 0.049 Å). The octyl chain adopts an all-trans conformation.

Entities:  

Year:  2010        PMID: 21580788      PMCID: PMC2983786          DOI: 10.1107/S1600536810011542

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological activity of quinoxaline derivatives, see: Kleim et al. (1995 ▶). For the anti­tumor and anti­tuberculous properties of quinoxaline derivatives, see: Abasolo et al. (1987 ▶); Rodrigo et al. (2002 ▶). For the anti­fungal, herbicidal, anti­dyslipidemic and anti-oxidative activity of quinoxaline derivatives, see: Jampilek et al. (2005 ▶); Sashidhara et al. (2009 ▶); Watkins et al. (2009 ▶).

Experimental

Crystal data

C17H24N2S M = 288.44 Triclinic, a = 7.3514 (3) Å b = 8.2978 (3) Å c = 14.2168 (5) Å α = 92.275 (2)° β = 98.706 (2)° γ = 103.810 (2)° V = 829.86 (5) Å3 Z = 2 Mo Kα radiation μ = 0.19 mm−1 T = 296 K 0.26 × 0.17 × 0.16 mm

Data collection

Bruker APEXII CCD detector diffractometer 29319 measured reflections 6513 independent reflections 3251 reflections with I > 2σ(I) R int = 0.046

Refinement

R[F 2 > 2σ(F 2)] = 0.054 wR(F 2) = 0.161 S = 1.00 6513 reflections 183 parameters H-atom parameters constrained Δρmax = 0.24 e Å−3 Δρmin = −0.21 e Å−3 Data collection: APEX2 (Bruker, 2005 ▶); cell refinement: SAINT (Bruker, 2005 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: XP (Sheldrick, 2008 ▶); software used to prepare material for publication: publCIF (Westrip, 2010 ▶). Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536810011542/bt5230sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810011542/bt5230Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C17H24N2SZ = 2
Mr = 288.44F(000) = 312
Triclinic, P1Dx = 1.154 Mg m3
Hall symbol: -P 1Melting point: 374 K
a = 7.3514 (3) ÅMo Kα radiation, λ = 0.71073 Å
b = 8.2978 (3) ÅCell parameters from 2685 reflections
c = 14.2168 (5) Åθ = 2.5–27.3°
α = 92.275 (2)°µ = 0.19 mm1
β = 98.706 (2)°T = 296 K
γ = 103.810 (2)°Block, colourless
V = 829.86 (5) Å30.26 × 0.17 × 0.16 mm
Bruker APEXII CCD detector diffractometer3251 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.046
graphiteθmax = 33.6°, θmin = 2.8°
ω and φ scansh = −10→11
29319 measured reflectionsk = −12→12
6513 independent reflectionsl = −22→22
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.054Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.161H-atom parameters constrained
S = 1.00w = 1/[σ2(Fo2) + (0.0769P)2 + 0.0189P] where P = (Fo2 + 2Fc2)/3
6513 reflections(Δ/σ)max < 0.001
183 parametersΔρmax = 0.24 e Å3
0 restraintsΔρmin = −0.21 e Å3
Experimental. The data collection nominally covered a sphere of reciprocal space, by a combination of seven sets of exposures; each set had a different φ angle for the crystal and each exposure covered 0.5° in ω and 25 seconds in time. The crystal-to-detector distance was 37.5 mm.
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
S10.61857 (5)0.28251 (5)0.04284 (3)0.05291 (14)
N20.67349 (16)0.13786 (14)−0.11823 (8)0.0467 (3)
C80.54850 (18)0.17628 (16)−0.07085 (10)0.0426 (3)
N10.28116 (16)0.05407 (15)−0.19181 (9)0.0518 (3)
C100.87038 (19)0.29990 (18)0.06244 (11)0.0493 (3)
H10A0.89330.18960.05970.059*
H10B0.92630.35960.01240.059*
C70.34717 (18)0.13428 (17)−0.10860 (11)0.0472 (3)
C10.6056 (2)0.05508 (17)−0.20663 (10)0.0476 (3)
C110.9631 (2)0.39073 (19)0.15840 (11)0.0552 (4)
H11A0.90860.32980.20850.066*
H11B0.93790.50020.16150.066*
C60.4093 (2)0.01226 (17)−0.24318 (10)0.0503 (3)
C121.1760 (2)0.40888 (19)0.17481 (11)0.0550 (4)
H12A1.19900.29890.16890.066*
H12B1.22870.47110.12470.066*
C141.4944 (2)0.5180 (2)0.27832 (11)0.0593 (4)
H14A1.52010.40970.26890.071*
H14B1.53690.58310.22700.071*
C131.2816 (2)0.4944 (2)0.27024 (11)0.0571 (4)
H13A1.23720.42850.32090.069*
H13B1.25390.60220.27860.069*
C50.3444 (3)−0.0724 (2)−0.33399 (12)0.0654 (4)
H50.2151−0.1026−0.35800.078*
C151.6108 (2)0.6024 (2)0.37177 (12)0.0659 (4)
H15A1.57570.53410.42310.079*
H15B1.58110.70850.38350.079*
C90.2124 (2)0.1842 (2)−0.05151 (13)0.0626 (4)
H9A0.08600.1513−0.08720.094*
H9B0.24800.3028−0.03770.094*
H9C0.21660.13080.00720.094*
C20.7318 (3)0.0135 (2)−0.26280 (12)0.0630 (4)
H20.86160.0409−0.23970.076*
C161.8230 (3)0.6316 (3)0.37289 (14)0.0818 (6)
H16A1.85230.52470.36320.098*
H16B1.85620.69560.31960.098*
C30.6642 (3)−0.0667 (2)−0.35107 (13)0.0737 (5)
H30.7489−0.0927−0.38800.088*
C40.4702 (3)−0.1106 (2)−0.38715 (13)0.0748 (5)
H40.4266−0.1660−0.44750.090*
C171.9438 (3)0.7205 (3)0.46263 (17)0.1066 (8)
H17A1.92240.82950.47080.160*
H17B2.07520.73030.45870.160*
H17C1.91140.65890.51600.160*
U11U22U33U12U13U23
S10.0394 (2)0.0656 (2)0.0517 (2)0.01121 (16)0.00697 (15)−0.00649 (16)
N20.0370 (6)0.0531 (6)0.0480 (7)0.0077 (5)0.0075 (5)0.0010 (5)
C80.0345 (7)0.0467 (7)0.0450 (7)0.0078 (5)0.0052 (5)0.0039 (6)
N10.0393 (6)0.0597 (7)0.0529 (7)0.0106 (5)−0.0004 (5)0.0030 (6)
C100.0370 (7)0.0551 (8)0.0511 (8)0.0046 (6)0.0052 (6)−0.0026 (6)
C70.0346 (7)0.0498 (7)0.0555 (9)0.0087 (6)0.0049 (6)0.0064 (6)
C10.0454 (8)0.0501 (7)0.0467 (8)0.0093 (6)0.0090 (6)0.0041 (6)
C110.0465 (8)0.0620 (9)0.0523 (9)0.0077 (7)0.0041 (7)−0.0011 (7)
C60.0489 (8)0.0518 (8)0.0468 (8)0.0095 (6)0.0018 (6)0.0059 (6)
C120.0475 (8)0.0601 (8)0.0507 (8)0.0058 (7)0.0004 (7)0.0006 (7)
C140.0528 (9)0.0644 (9)0.0518 (9)0.0041 (7)−0.0018 (7)0.0044 (7)
C130.0518 (9)0.0618 (9)0.0514 (9)0.0071 (7)0.0009 (7)0.0010 (7)
C50.0667 (11)0.0707 (10)0.0515 (9)0.0130 (8)−0.0048 (8)−0.0018 (8)
C150.0579 (10)0.0745 (10)0.0554 (9)0.0070 (8)−0.0045 (8)−0.0010 (8)
C90.0383 (8)0.0779 (10)0.0721 (11)0.0181 (7)0.0082 (7)−0.0061 (8)
C20.0597 (10)0.0699 (10)0.0616 (10)0.0151 (8)0.0203 (8)−0.0006 (8)
C160.0637 (12)0.1066 (15)0.0644 (11)0.0139 (10)−0.0064 (9)−0.0109 (10)
C30.0848 (14)0.0779 (11)0.0645 (11)0.0220 (10)0.0298 (10)−0.0013 (9)
C40.0960 (15)0.0749 (11)0.0481 (10)0.0159 (10)0.0067 (10)−0.0051 (8)
C170.0735 (14)0.138 (2)0.0857 (16)0.0068 (13)−0.0159 (12)−0.0248 (14)
S1—C81.7530 (14)C14—H14B0.9700
S1—C101.7995 (14)C13—H13A0.9700
N2—C81.3077 (18)C13—H13B0.9700
N2—C11.3705 (18)C5—C41.363 (3)
C8—C71.4485 (18)C5—H50.9300
N1—C71.2990 (18)C15—C161.518 (2)
N1—C61.373 (2)C15—H15A0.9700
C10—C111.5119 (19)C15—H15B0.9700
C10—H10A0.9700C9—H9A0.9600
C10—H10B0.9700C9—H9B0.9600
C7—C91.491 (2)C9—H9C0.9600
C1—C21.405 (2)C2—C31.361 (2)
C1—C61.411 (2)C2—H20.9300
C11—C121.517 (2)C16—C171.493 (2)
C11—H11A0.9700C16—H16A0.9700
C11—H11B0.9700C16—H16B0.9700
C6—C51.403 (2)C3—C41.395 (3)
C12—C131.513 (2)C3—H30.9300
C12—H12A0.9700C4—H40.9300
C12—H12B0.9700C17—H17A0.9600
C14—C151.511 (2)C17—H17B0.9600
C14—C131.515 (2)C17—H17C0.9600
C14—H14A0.9700
C8—S1—C10101.52 (7)C14—C13—H13A109.2
C8—N2—C1116.84 (12)C12—C13—H13B109.2
N2—C8—C7122.43 (13)C14—C13—H13B109.2
N2—C8—S1120.95 (10)H13A—C13—H13B107.9
C7—C8—S1116.62 (10)C4—C5—C6120.31 (17)
C7—N1—C6117.62 (12)C4—C5—H5119.8
C11—C10—S1110.83 (10)C6—C5—H5119.8
C11—C10—H10A109.5C14—C15—C16112.72 (16)
S1—C10—H10A109.5C14—C15—H15A109.0
C11—C10—H10B109.5C16—C15—H15A109.0
S1—C10—H10B109.5C14—C15—H15B109.0
H10A—C10—H10B108.1C16—C15—H15B109.0
N1—C7—C8121.19 (13)H15A—C15—H15B107.8
N1—C7—C9119.08 (12)C7—C9—H9A109.5
C8—C7—C9119.73 (13)C7—C9—H9B109.5
N2—C1—C2120.09 (13)H9A—C9—H9B109.5
N2—C1—C6120.89 (13)C7—C9—H9C109.5
C2—C1—C6119.02 (14)H9A—C9—H9C109.5
C10—C11—C12111.23 (13)H9B—C9—H9C109.5
C10—C11—H11A109.4C3—C2—C1119.96 (16)
C12—C11—H11A109.4C3—C2—H2120.0
C10—C11—H11B109.4C1—C2—H2120.0
C12—C11—H11B109.4C17—C16—C15114.54 (18)
H11A—C11—H11B108.0C17—C16—H16A108.6
N1—C6—C5119.52 (14)C15—C16—H16A108.6
N1—C6—C1121.03 (13)C17—C16—H16B108.6
C5—C6—C1119.45 (14)C15—C16—H16B108.6
C13—C12—C11115.33 (13)H16A—C16—H16B107.6
C13—C12—H12A108.4C2—C3—C4121.23 (17)
C11—C12—H12A108.4C2—C3—H3119.4
C13—C12—H12B108.4C4—C3—H3119.4
C11—C12—H12B108.4C5—C4—C3120.02 (17)
H12A—C12—H12B107.5C5—C4—H4120.0
C15—C14—C13115.44 (14)C3—C4—H4120.0
C15—C14—H14A108.4C16—C17—H17A109.5
C13—C14—H14A108.4C16—C17—H17B109.5
C15—C14—H14B108.4H17A—C17—H17B109.5
C13—C14—H14B108.4C16—C17—H17C109.5
H14A—C14—H14B107.5H17A—C17—H17C109.5
C12—C13—C14112.02 (13)H17B—C17—H17C109.5
C12—C13—H13A109.2
  4 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Quinaldine derivatives: preparation and biological activity.

Authors:  Josef Jampilek; Martin Dolezal; Jiri Kunes; Vladimir Buchta; Luis Silva; Katarina Kralova
Journal:  Med Chem       Date:  2005-11       Impact factor: 2.745

3.  Antidyslipidemic and antioxidative activities of 8-hydroxyquinoline derived novel keto-enamine Schiffs bases.

Authors:  Koneni V Sashidhara; Abdhesh Kumar; Gitika Bhatia; M M Khan; A K Khanna; J K Saxena
Journal:  Eur J Med Chem       Date:  2008-08-22       Impact factor: 6.514

4.  Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication.

Authors:  J P Kleim; R Bender; R Kirsch; C Meichsner; A Paessens; M Rösner; H Rübsamen-Waigmann; R Kaiser; M Wichers; K E Schneweis
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.